Physician

Blake Isernhagen, MD

According to 2025 Medicare claims, Blake Isernhagen, MD (NPI: 1336469444) practices ophthalmology in the Lexington-Fayette, KY market, with the plurality of this provider's patient population coming from Fayette, KY. This provider's primary affiliated billing organization is RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (NPI: 1619949971; TIN: 610918053) and primary practice location at 41101-3009.

Isernhagen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 41,144 HCPCS/CPT codes, and received $3,299,132 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,113 prescription claims across 314 beneficiaries totaling $74,515 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 50 records totaling $15,517. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $7,898 to $3,299,132. Similarly, Part D prescription costs have risen steadily, from $7,563 to $74,515. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $7,898 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $967,113 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,707,376 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,165,110 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,646,382 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,786,650 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,567,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,095,529 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,280,810 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,299,132 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015100157$7,898
20166653,614$967,113
20171,4489,698$2,707,376
20181,35411,968$3,165,110
20191,29713,666$3,646,382
20201,44113,888$3,786,650
20211,26312,443$3,567,444
20221,05012,557$3,095,529
202392128,041$3,280,810
202491941,144$3,299,132

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$93K2015 Drug cost: $7,563 (USD; Tot_Drug_Cst)2016 Drug cost: $3,572 (USD; Tot_Drug_Cst)2017 Drug cost: $29,336 (USD; Tot_Drug_Cst)2018 Drug cost: $52,330 (USD; Tot_Drug_Cst)2019 Drug cost: $64,880 (USD; Tot_Drug_Cst)2020 Drug cost: $77,158 (USD; Tot_Drug_Cst)2021 Drug cost: $86,238 (USD; Tot_Drug_Cst)2022 Drug cost: $84,261 (USD; Tot_Drug_Cst)2023 Drug cost: $92,508 (USD; Tot_Drug_Cst)2024 Drug cost: $74,515 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201526108$7,563
20162856$3,572
2017147407$29,336
2018192608$52,330
2019246747$64,880
2020338906$77,158
2021358967$86,238
20223531,002$84,261
20233111,083$92,508
20243141,113$74,515

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2822,278$653
67028Injection of drug into eye4171,598$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more281362$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more485746$62
92134Imaging of retina8042,129$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate1496,274$15,891
CombiganBrimonidine Tartrate/Timolol261,643$9,825
AtovaquoneAtovaquone18339$9,646
Prednisolone AcetatePrednisolone Acetate1587,777$6,953
ValacyclovirValacyclovir Hcl934,188$4,539

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.50$15,517Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Blake Isernhagen, MD?

Tedicare shows public-source Medicare data for Blake Isernhagen, MD (NPI 1336469444), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Blake Isernhagen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Blake Isernhagen, MD?

Blake Isernhagen, MD is linked to RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (billing NPI 1619949971) in the available physician profile data.

Does Blake Isernhagen, MD have Open Payments data?

Blake Isernhagen, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.